🇺🇸 FDA
Patent

US 10266565

Peptide mimetic ligands of polo-like kinase 1 polo box domain and methods of use

granted A61KA61K38/00A61K47/60

Quick answer

US patent 10266565 (Peptide mimetic ligands of polo-like kinase 1 polo box domain and methods of use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Apr 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K38/00, A61K47/60, A61P, A61P35/00